Market Overview:
The global contrast media API market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for contrast media APIs for various applications such as X-ray & CT, MRI, and ultrasound. North America is expected to hold the largest share of the global contrast media API market in 2018, followed by Europe and Asia Pacific. However, Asia Pacific is projected to witness the highest CAGR during the forecast period due to rising demand from countries such as China and India.
Product Definition:
Contrast Media API is an interface that helps developers to create and manage contrast media within their applications. Contrast media are substances used to improve the visibility of certain body tissues when scanned by a diagnostic imaging device such as an MRI or X-ray machine. Contrast media can be injected into a patient's bloodstream, swallowed, or inhaled.
Iodine:
Iodine is a halogen element that has been used as a contrast media in medical imaging for over two centuries. It was first introduced as an antimicrobial agent in 1811 by the French physician Louis-Nicolas Vauquelin. Iodine was identified as an element of particular interest for its strong radio-protective and radio-active properties, which were later on utilized to develop thyroid hormones and nuclear radiation (X rays).
Gadolinium:
Gadolinium is a rare earth metal with a bright luster. It has the highest electrical and thermal conductivity of any metal, which makes it useful in contrast media for MRI scans. Gadolinium is used as an additive in contrast media to improve its ability to enhance MR images during magnetic resonance imaging (MRI).
Application Insights:
MRI contrast media accounted for the largest revenue share in 2017 owing to its wide application in medical imaging. MRI is widely used to image the spinal cord, brain, and nerve roots as well as soft tissue injuries. Increasing R&D activities pertaining to advanced MRI techniques that can detect even small amounts of water or other fluids in the body is expected to drive growth over the forecast period. Ultrasound contrast media is anticipated to witness significant growth due double edged sword effects; on one hand it has been found helpful in diagnosis of various conditions on ultrasound images but on other hand it also creates problems due interpretation by inexperienced users leading them towards adoption of computerized tomography which further drives demand for NCMA API solution providers.
Regional Analysis:
North America dominated the global contrast media API market in 2017. The presence of well-established healthcare infrastructure and increasing R&D investment by manufacturers are some factors driving the growth of this regional market. In addition, growing adoption of advanced diagnostic technologies is also expected to drive demand for contrast media over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising medical tourism and improving healthcare infrastructure in emerging countries such as India, China, and Japan. Moreover, an increase in government initiatives aimed at improving public health system is further expected to fuel demand for contrast media over the next eight years.
Growth Factors:
- Increasing demand for contrast media in diagnostic and therapeutic procedures
- Growing number of hospitals and imaging centers
- Technological advancements in contrast media delivery systems
- Rising incidence of cardiovascular diseases and other medical conditions requiring contrast media injections
- Proliferation of private diagnostic clinics
Scope Of The Report
Report Attributes
Report Details
Report Title
Contrast Media API Market Research Report
By Type
Iodine, Gadolinium
By Application
X-ray & CT, MRI, Ultrasound
By Companies
Starry Pharmaceuti, Hovione, Interpharma, Divis, Costcon Healthcare, LGM Pharma, Avigna Chemitech Private Limited, THINQ Pharma, Brother Enterprises Holding, Zhejiang Hichi Pharmaceutical Corporation Limited, Starry Pharmaceuti
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
164
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Contrast Media API Market Report Segments:
The global Contrast Media API market is segmented on the basis of:
Types
Iodine, Gadolinium
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
X-ray & CT, MRI, Ultrasound
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Starry Pharmaceuti
- Hovione
- Interpharma
- Divis
- Costcon Healthcare
- LGM Pharma
- Avigna Chemitech Private Limited
- THINQ Pharma
- Brother Enterprises Holding
- Zhejiang Hichi Pharmaceutical Corporation Limited
- Starry Pharmaceuti
Highlights of The Contrast Media API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Iodine
- Gadolinium
- By Application:
- X-ray & CT
- MRI
- Ultrasound
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Contrast Media API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Contrast Media API is a platform-agnostic media streaming and analytics service that helps developers build applications that can monitor, analyze, and predict how viewers are interacting with their content.
Some of the major companies in the contrast media api market are Starry Pharmaceuti, Hovione, Interpharma, Divis, Costcon Healthcare, LGM Pharma, Avigna Chemitech Private Limited, THINQ Pharma, Brother Enterprises Holding, Zhejiang Hichi Pharmaceutical Corporation Limited, Starry Pharmaceuti.
The contrast media api market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contrast Media API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Contrast Media API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Contrast Media API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Contrast Media API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Contrast Media API Market Size & Forecast, 2018-2028
4.5.1 Contrast Media API Market Size and Y-o-Y Growth
4.5.2 Contrast Media API Market Absolute $ Opportunity
Chapter 5 Global Contrast Media API Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Contrast Media API Market Size Forecast by Type
5.2.1 Iodine
5.2.2 Gadolinium
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Contrast Media API Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Contrast Media API Market Size Forecast by Applications
6.2.1 X-ray & CT
6.2.2 MRI
6.2.3 Ultrasound
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Contrast Media API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Contrast Media API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Contrast Media API Analysis and Forecast
9.1 Introduction
9.2 North America Contrast Media API Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Contrast Media API Market Size Forecast by Type
9.6.1 Iodine
9.6.2 Gadolinium
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Contrast Media API Market Size Forecast by Applications
9.10.1 X-ray & CT
9.10.2 MRI
9.10.3 Ultrasound
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Contrast Media API Analysis and Forecast
10.1 Introduction
10.2 Europe Contrast Media API Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Contrast Media API Market Size Forecast by Type
10.6.1 Iodine
10.6.2 Gadolinium
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Contrast Media API Market Size Forecast by Applications
10.10.1 X-ray & CT
10.10.2 MRI
10.10.3 Ultrasound
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Contrast Media API Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Contrast Media API Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Contrast Media API Market Size Forecast by Type
11.6.1 Iodine
11.6.2 Gadolinium
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Contrast Media API Market Size Forecast by Applications
11.10.1 X-ray & CT
11.10.2 MRI
11.10.3 Ultrasound
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Contrast Media API Analysis and Forecast
12.1 Introduction
12.2 Latin America Contrast Media API Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Contrast Media API Market Size Forecast by Type
12.6.1 Iodine
12.6.2 Gadolinium
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Contrast Media API Market Size Forecast by Applications
12.10.1 X-ray & CT
12.10.2 MRI
12.10.3 Ultrasound
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Contrast Media API Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Contrast Media API Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Contrast Media API Market Size Forecast by Type
13.6.1 Iodine
13.6.2 Gadolinium
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Contrast Media API Market Size Forecast by Applications
13.10.1 X-ray & CT
13.10.2 MRI
13.10.3 Ultrasound
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Contrast Media API Market: Competitive Dashboard
14.2 Global Contrast Media API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Starry Pharmaceuti
14.3.2 Hovione
14.3.3 Interpharma
14.3.4 Divis
14.3.5 Costcon Healthcare
14.3.6 LGM Pharma
14.3.7 Avigna Chemitech Private Limited
14.3.8 THINQ Pharma
14.3.9 Brother Enterprises Holding
14.3.10 Zhejiang Hichi Pharmaceutical Corporation Limited
14.3.11 Starry Pharmaceuti
